Interra Health is helping Medicare patients access $50-per-month GLP-1s through the new Bridge program. The post Interra Health Adds GLP-1 Bridge Program Support appeared first on MedCity News.

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView Capital. The platform uses ambient sensors and computer vision to predict falls before they happen. The post Inspiren Rakes In $70M to Scale Its AI-Powered Senior Living Platform appeared first on MedCity News.

The problem is not that companies have failed to make easy-to-use applications. Rather, it’s that there have been limitations to what software can realistically do in a modern healthcare environment. The post Healthcare Needs Software That Handles a Messy Reality appeared first on MedCity News.

Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health Investors and ARTIS also participated. The post GenHealth.ai Raises $16.5M to Automate Healthcare Administrative Tasks appeared first on MedCity News.

Nutromics earned FDA breakthrough device designation for its wearable patch that tracks vancomycin levels in real time. The device aims to replace the periodic blood draws currently used to dose the tricky-to-manage antibiotic. The post Nutromics Nabs FDA Breakthrough Status for Antibiotic Monitoring Patch appeared first on MedCity News.

Automation in healthcare gains value when it strengthens the conditions that allow clinicians to practice at the top of their training. The post Augmenting the Systems That Support Patient Mobility appeared first on MedCity News.

A Georgetown report outlines three strategies to improve health insurance by lowering costs, simplifying coverage and protecting patients from corporate abuses. The post 3 Strategies to Improve Health Insurance, Per Georgetown Report appeared first on MedCity News.

Health Wildcatters, a Dallas accelerator and INVEST Digital Health partner, has announced the healthcare startups in its latest cohort. Join us at INVEST DIgital Health on October 29 and meet them in person! The post At INVEST Digital Health, Health Wildcatters Will Highlight Latest Cohort of Startups appeared first on MedCity News.

Imprivata CEO Fran Rosch said AI agents should be treated similarly to the way hospitals treat a new contract nurse — vetted, monitored and then cut off as soon as the job is done. The post Imprivata CEO: AI Agents Need the Same Scrutiny as an Unvetted Contract Nurse appeared first on MedCity News.

The same mechanics can now help people meet new Medicaid work requirements or exemptions, increase referrals to evidence-based health interventions, and dramatically increase enrollment in vital programs that improve health outcomes and reduce inequities. The post What Health Equity Champions Can Learn from Pharmaceutical Sales appeared first on MedCity News.

[Sponsored] A webinar scheduled for September 30 from 1pm to 2pm ET will review the 2026 Healthcare AI Readiness Index and highlight some of the report’s takeaways, exploring the operational, regulatory and security challenges accompanying AI deployment. The post Healthcare Executives Weigh In: AI Readiness and the Growing Risk of Cybersecurity Threats appeared first on MedCity News.

A PHTI analysis found that virtual CKD management programs have little impact on disease progression or healthcare spending and recommends shifting the focus toward earlier diagnosis and treatment. The post Virtual CKD Solutions Don’t Slow Disease Progression or Reduce Costs, Report Finds appeared first on MedCity News.

Michelle Watson, Lifepoint Health’s chief nurse executive, believes ambient listening and AI-powered patient prioritization are helping nurses reclaim time on tasks that don’t require clinical judgment. The goal is to free nurses up for the work that actually requires their expertise. The post How Lifepoint Health Is Using AI to Give Nurses Their Time Back appeared first on MedCity News.

Patient trust, physician credibility, and payer goodwill are not soft considerations alongside the balance sheet; they are the mechanism by which a pharmaceutical product generates revenue over time. The post Ethics Isn’t a Pharma Value — It’s a Competitive Moat appeared first on MedCity News.

Forus’ $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel. The post Forus Secures $150M Series C, Reaches $3B Valuation appeared first on MedCity News.